Sever recurrent early onset preeclampsia in second trimester , of pregnancy a case report

Authors
Alamtaj Samsami 1
Tahere Poordast 1
Shaghayegh Moradi Alamdarloo 2
Atefe Hashemi 3
Behnaz Razavi 3
1 Infertility Research Center, Department of Obstetrics and Gynecology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
2 Maternal-fetal medicine Research Center, Department of Obstetrics and Gynecology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
3 Student research committee, Shiraz University of Medical Sciences, Shiraz, Iran
10.52547/jmj.18.1.29
Abstract
Introduction: Pregnancy toxemia causes many pregnant mothers at risk for adverse midwifery complications and sometimes the risk of death. If this complication occurs early in the second trimester of pregnancy, the mother will be deprived of having a child as a result of this complicated pregnancy. Here we present a woman who has had premature pregnancy toxemia. The known risk factors in this woman were not positive.
Keywords
Preeclampsia
Pregnancy
Recurrent
1. Duley L. Pre-eclampsia, eclampsia, and hypertension. BMJ clinical evidence. 2011;2011. 2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet (London, England). 2010;376(9741):631-44. 3. Giannakou K, Evangelou E, Papatheodorou SI. Genetic and non‐genetic risk factors for pre‐eclampsia: umbrella review of systematic reviews and meta‐analyses of observational studies. Ultrasound in Obstetrics & Gynecology. 2018;51(6):720-30. 4. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstetrics and gynecology. 2010;116(2 Pt 1):402-14. 5. Groeneveld E, Lambers MJ, Lambalk CB, Broeze KA, Haapsamo M, de Sutter P, et al. Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta-analysis with individual patient data. Human reproduction (Oxford, England). 2013;28(6):1480-8. 6. Ornaghi S, Paidas MJ. Novel Therapy for the Treatment of Early-Onset Preeclampsia. Clinical obstetrics and gynecology. 2017;60(1):169-82. 7. Boene H, Vidler M, Sacoor C, Nhama A, Nhacolo A, Bique C, et al. Community perceptions of pre-eclampsia and eclampsia in southern Mozambique. Reproductive health. 2016;13 Suppl 1:33. 8. Shao Y, Qiu J, Huang H, Mao B, Dai W, He X, et al. Pre-pregnancy BMI, gestational weight gain and risk of preeclampsia: a birth cohort study in Lanzhou, China. BMC pregnancy and childbirth. 2017;17(1):400. 9. Duan H, Zhao G, Xu B, Hu S, Li J. Maternal Serum PLGF, PAPPA, beta-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia. Clinical laboratory. 2017;63(5):921-5. 10. Boyd HA, Tahir H, Wohlfahrt J, Melbye M. Associations of personal and family preeclampsia history with the risk of early-, intermediate- and late-onset preeclampsia. American journal of epidemiology. 2013;178(11):1611-9.